Ultrasound Detected Subcutaneous Changes in a Pediatric Cohort After Initiation of a New Insulin Pump or Glucose Sensor.
暂无分享,去创建一个
[1] T. Klupa,et al. Insulin-induced Lipohypertrophy in Patients with Type 1 Diabetes Mellitus Treated with an Insulin Pump , 2022, International journal of endocrinology.
[2] R. Rogers,et al. Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study , 2021, BMJ Open Diabetes Research & Care.
[3] Paul A. Harris,et al. The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.
[4] A. Deeb,et al. Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes , 2019, Diabetes Therapy.
[5] K. Nørgaard,et al. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study. , 2018, Diabetes technology & therapeutics.
[6] B. Olsen,et al. High frequencies of dermatological complications in children using insulin pumps or sensors , 2018, Pediatric diabetes.
[7] F. Bertuzzi,et al. Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus , 2017, Journal of Endocrinological Investigation.
[8] I. Hirsch,et al. New Insulin Delivery Recommendations. , 2016, Mayo Clinic proceedings.
[9] L. Heinemann,et al. Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control , 2016, Diabetes Care.
[10] R. Hovorka,et al. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons , 2016, Expert opinion on drug delivery.
[11] R. Hovorka,et al. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics , 2015, Diabetes/metabolism research and reviews.
[12] Michael A. Gibney,et al. Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. , 2014, Diabetes technology & therapeutics.
[13] José G. B. Derraik,et al. Effects of Age, Gender, BMI, and Anatomical Site on Skin Thickness in Children and Adults with Diabetes , 2014, PloS one.
[14] D. Lo Presti,et al. Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection , 2012, Pediatric diabetes.
[15] Michael A. Gibney,et al. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations , 2010, Current medical research and opinion.
[16] H. Mortensen,et al. Long‐term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time , 2009, Pediatric diabetes.
[17] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[18] E. Robinson,et al. An angled insertion technique using 6‐mm needles markedly reduces the risk of intramuscular injections in children and adolescents , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[19] Sevgi Kızılcı,et al. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. , 2007, Diabetes research and clinical practice.
[20] A. Daneman,et al. Dermatological complications of continuous subcutaneous insulin infusion in children and adolescents. , 2008, The Journal of pediatrics.
[21] B. Boehm,et al. Early hypoglycaemia after accidental intramuscular injection of insulin glargine , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[22] U. Johansson,et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. , 2005, Diabetes care.
[23] O. D. Wolthers,et al. Methodological aspects of high‐frequency ultrasound of skin in children , 2004, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.
[24] M. Hassan,et al. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. , 1999, Diabetes care.
[25] M. Sargent,et al. Subcutaneous or intramuscular insulin injections. , 1991, Archives of disease in childhood.
[26] P. Home,et al. Morphology of Palpably Abnormal Injection Sites and Effects on Absorption of Isophane(NPH) Insulin , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[27] B. Linde,et al. Hypoglycemia Risk During Exercise After Intramuscular Injection of Insulin in Thigh in IDDM , 1990, Diabetes Care.
[28] B. Linde,et al. Effects of Accidental Intramuscular Injection on Insulin Absorption in IDDM , 1988, Diabetes Care.
[29] Qifu Li,et al. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact. , 2017, Diabetes technology & therapeutics.
[30] Christiane,et al. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.
[31] P A Cleary,et al. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). , 2001, The Journal of pediatrics.